WATCHMAN Device Shows Promise for Stroke Prevention in Atrial Fibrillation
Boston Scientific's WATCHMAN device, designed for stroke prevention in patients with atrial fibrillation, has shown promising results in a recent trial presented at the American College of Cardiology (ACC) conference.
Bōshìdùn kēxué gōngsī de WATCHMAN shèbèi zhǔnzài yùfáng xīnfáng zhèndòng huànzhě de zhòngfēng, zài zuìjìn de Měiguó xīnzàngbìngxuéhuì (ACC) huìyì shàng zhǎnshìle yǒu xīwàng de jiéguǒ.
波士顿科学公司的WATCHMAN设备旨在预防心房颤动患者的中风，在最近的美国心脏病学会（ACC）会议上展示了有希望的结果。
The CHAMPION-AF study revealed that patients using the WATCHMAN device had a significantly lower incidence of stroke compared to those on traditional anticoagulant therapy.
CHAMPION-AF yánjiū xiǎnshì, shǐyòng WATCHMAN shèbèi de huànzhě yǔ jiēshòu chuántǒng kàngníng zhìliáo de huànzhě xiāngbǐ, zhòngfēng fāshēng lǜ xiǎnzhù jiàngdī.
CHAMPION-AF研究显示，使用WATCHMAN设备的患者与接受传统抗凝治疗的患者相比，中风发生率显著降低。
The trial's findings suggest that the WATCHMAN device may provide an effective alternative for patients who are at increased risk of stroke but cannot tolerate long-term anticoagulation due to bleeding risks or other factors.
Shiyàn jiéguǒ biǎomíng, WATCHMAN shèbèi kěnéng wèi miànlín zhòngfēng fēngxiǎn jiādà de huànzhě tígōng yī zhǒng yǒuxiào de tìdài xuǎnzé, dàn yīn chūxuè fēngxiǎn huò qítā yīnsù ér wúfǎ nàishòu chángqī kàngníng.
试验结果表明，WATCHMAN设备可能为面临中风风险加大的患者提供一种有效的替代选择，但因出血风险或其他因素而无法耐受长期抗凝。
With over 200,000 patients treated worldwide, Boston Scientific is optimistic about the device's role in improving patient outcomes in stroke prevention associated with atrial fibrillation.
Quánqiú yǐyǒu chāoguò 200,000 míng huànzhě jiēshòu zhìliáo, Bōshìdùn kēxué gōngsī duì gāi shèbèi zài gǎishàn yǔ xīnfáng zhèndòng xiāngguān de zhòngfēng yùfáng huànzhě jiéguǒ zhōng de zuòyòng gǎndào lèguān.
全球已有超过200,000名患者接受治疗，波士顿科学公司对该设备在改善与心房颤动相关的中风预防患者结果中的作用感到乐观。
The success of the WATCHMAN device in the CHAMPION-AF study highlights its potential impact on medical practices and guidelines related to atrial fibrillation management.
WATCHMAN shèbèi zài CHAMPION-AF yánjiū zhōng de chénggōng tūxiànle tā duì xīnfáng zhèndòng guǎnlǐ xiāngguān yīliáo shíjiàn hé zhǐnán de qiánzài yǐngxiǎng.
WATCHMAN设备在CHAMPION-AF研究中的成功凸显了它对心房颤动管理相关医疗实践和指南的潜在影响。
Boston Scientific plans to continue its research and development efforts to enhance the device further and expand its application in stroke prevention.
Bōshìdùn kēxué jìhuà jìxù qí yánjiū hé kāifā gōngzuò, yǐ jìnyībù zēngqiáng gāi shèbèi bìng kuò dà qí zài zhòngfēng yùfáng zhōng de yìngyòng.
波士顿科学计划继续其研究和开发工作，以进一步增强该设备并扩大其在中风预防中的应用。
Based on this article